Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Impact of in-hospital blood pressure variability on clinical outcomes in patients with symptomatic peripheral arterial disease


Various types of blood pressure (BP) variability have been recognized as risk factors for future cardiovascular events. However, the prognostic impact of in-hospital BP variability in patients with symptomatic peripheral arterial disease (PAD) has not yet been thoroughly investigated. A total of 386 patients with PAD who underwent endovascular therapy in two hospitals were retrospectively included. BP variability was assessed by the coefficient of variation (CV) of systolic BP measured during hospitalization by trained nurses. The primary endpoint was a composite of major adverse cardiovascular events (cardiovascular death, acute coronary syndrome, stroke, and hospitalization for heart failure) and major adverse limb events (major amputation, acute limb ischemia, and surgical limb revascularization). The mean systolic BP and the CV of systolic BP during hospitalization were 130.8 ± 15.7 mmHg and 11.2 ± 4.1%, respectively. During the median follow-up period of 22 months, 80 patients (21%) reached the primary endpoint. Receiver operating characteristic curve analysis showed that the CV of systolic BP significantly predicted major adverse cardiovascular and limb events (area under the curve 0.60, best cutoff value 9.8, P = 0.01). Using the best cutoff value, patients with high BP variability (n = 242) had a higher risk of clinical events than those with low BP variability (n = 144) (26% vs. 12%, P < 0.001). Multivariable analysis indicated that the CV of systolic BP, age, hemodialysis, and atrial fibrillation were associated with the primary endpoint. In conclusion, greater in-hospital systolic BP variability was associated with major adverse cardiovascular and limb events in patients with symptomatic PAD undergoing endovascular therapy.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1


  1. 1.

    Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40.

    Article  Google Scholar 

  2. 2.

    Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lüders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36:932–8.

    Article  Google Scholar 

  3. 3.

    Steg PG, Bhatt DL, Wilson PWF, D’Agostino R, Ohman EM, Röther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206.

    CAS  Article  Google Scholar 

  4. 4.

    Feringa HHH, Bax JJ, Hoeks S, van Waning VH, Elhendy A, Karagiannis S, et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med. 2007;167:2482–9.

    CAS  Article  Google Scholar 

  5. 5.

    Sprengers RW, Janssen KJM, Moll FL, Verhaar MC, van der Graaf Y. SMART Study Group. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study. J Vasc Surg. 2009;50:1369–76.

    Article  Google Scholar 

  6. 6.

    Kumakura H, Kanai H, Aizaki M, Mitsui K, Araki Y, Kasama S, et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. J Vasc Surg. 2010;52:110–7.

    Article  Google Scholar 

  7. 7.

    Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg. 2014;59:1291–9.

    Article  Google Scholar 

  8. 8.

    Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383:1899–911.

    Article  Google Scholar 

  9. 9.

    Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.

    Article  Google Scholar 

  10. 10.

    Parati G, Stergiou GS, Dolan E, Bilo G. Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich). 2018;20:1133–7.

    Article  Google Scholar 

  11. 11.

    Fukuda K, Kai H, Kamouchi M, Hata J, Ago T, Nakane H, et al. Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke. Stroke. 2015;46:1832–9.

    Article  Google Scholar 

  12. 12.

    Hassan AKM, Rahman HA-E, Mohsen K, Dimitry SR. Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome. J Clin Hypertens (Greenwich). 2017;19:1252–9.

    CAS  Article  Google Scholar 

  13. 13.

    Saito K, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. In-Hospital Blood Pressure Variability: A Novel Prognostic Marker of Renal Function Decline and Cardiovascular Events in Patients with Coronary Artery Disease. Kidney Blood Press Res. 2020;45:748–57.

    Article  Google Scholar 

  14. 14.

    Yanagiuchi T, Kato T, Hiroe T, Yabuta J, Hanabusa K, Ota Y, et al. A model for predicting the time of early symptomatic restenosis after infrapopliteal angioplasty in patients with critical limb ischemia. Cardiovasc Interv Ther. 2020.

  15. 15.

    Shimada T, Habara S, Tanaka H, Kadota K. Plaque volume reduction after drug-coated balloon angioplasty for superficial femoral artery lesion. Cardiovasc Interv Ther. 2020.

  16. 16.

    Higashitani M, Anzai H, Mizuno A, Utsunomiya M, Umemoto T, Yamanaka T, et al. One-year limb outcome and mortality in patients undergoing revascularization therapy for acute limb ischemia: short-term results of the Edo registry. Cardiovasc Interv Ther. 2020.

  17. 17.

    Nakao M, Yamaguchi J, Otsuki H, Arashi H, Hagiwara N. Clinical outcomes of high-pressure balloon angioplasty for common femoral artery disease in contemporary practice. Cardiovasc Inter Ther. 2019;34:340–4.

    Article  Google Scholar 

  18. 18.

    Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.

    Article  Google Scholar 

  19. 19.

    Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143–55.

    Article  Google Scholar 

  20. 20.

    Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document. Circulation. 2018;137:2635–50.

    Article  Google Scholar 

  21. 21.

    Emdin CA, Anderson SG, Callender T, Conrad N, Salimi-Khorshidi G, Mohseni H, et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 2015;351:h4865.

    Article  Google Scholar 

  22. 22.

    Yeh C-H, Yu H-C, Huang T-Y, Huang P-F, Wang Y-C, Chen T-P, et al. High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: a New Biomarker from Old Measurement. Biomed Res Int. 2016;2016:9872945.

    PubMed  PubMed Central  Google Scholar 

  23. 23.

    Brennan MB, Guihan M, Budiman-Mak E, Kang H, Lobo JM, Sutherland BL, et al. Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers. J Hypertens. 2018;36:2177–84.

    CAS  Article  Google Scholar 

  24. 24.

    Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.

    Article  Google Scholar 

  25. 25.

    Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, et al. Association of Systolic Blood Pressure Variability with Mortality, Coronary Heart Disease, Stroke, and Renal Disease. J Am Coll Cardiol. 2016;68:1375–86.

    Article  Google Scholar 

  26. 26.

    Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30:1241–51.

    CAS  Article  Google Scholar 

  27. 27.

    Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B,P, et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469–80.

    CAS  Article  Google Scholar 

  28. 28.

    Muntner Paul ShimboDaichi, Tonelli Marcello ReynoldsKristi, Arnett Donna K, et al. The Relationship Between Visit-to-Visit Variability in Systolic Blood Pressure and All-Cause Mortality in the General Population. Hypertension. 2011;57:160–6.

    CAS  Article  Google Scholar 

  29. 29.

    Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, et al. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis. 2010;211:480–5.

    CAS  Article  Google Scholar 

  30. 30.

    Zahner GJ, Gruendl MA, Spaulding KA, Schaller MS, Hills NK, Gasper WJ, et al. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry. J Vasc Surg. 2017;66:1518–26.

    Article  Google Scholar 

  31. 31.

    Zhou Tan Lai, Henry Ronald MA, Stehouwer Coen DA, van Sloten Thomas T, Reesink Koen D, Kroon Abraham A. Blood Pressure Variability, Arterial Stiffness, and Arterial Remodeling. Hypertension. 2018;72:1002–10.

    Article  Google Scholar 

  32. 32.

    Alberts MJ, Bhatt DL, Mas J-L, Ohman EM, Hirsch AT, Röther J, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009;30:2318–26.

    Article  Google Scholar 

  33. 33.

    Yang M, Pan X, Liang Z, Huang X, Duan M, Cai H, et al. Association between blood pressure variability and the short-term outcome in patients with acute spontaneous subarachnoid hemorrhage. Hypertens Res. 2019;42:1701–7.

    Article  Google Scholar 

  34. 34.

    Itoga NK, Tawfik DS, Lee CK, Maruyama S, Leeper NJ, Chang TI. Association of blood pressure measurements with peripheral arterial disease events: reanalysis of the ALLHAT data. Circulation. 2018;138:1805–14.

    Article  Google Scholar 

  35. 35.

    Lee SE, Lee H-Y, Cho H-J, Choe W-S, Kim H, Choi J-O, et al. Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure. JACC Heart Fail. 2017;5:810–9.

    Article  Google Scholar 

  36. 36.

    Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, et al. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. JACC Cardiovasc Inter. 2014;7:792–8.

    Article  Google Scholar 

  37. 37.

    Webb AJ, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke. 2011;42:2860–5.

    CAS  Article  Google Scholar 

  38. 38.

    Lim HM, Chia YC, Ching SM, Chinna K. Number of blood pressure measurements needed to estimate long-term visit-to-visit systolic blood pressure variability for predicting cardiovascular risk: a 10-year retrospective cohort study in a primary care clinic in Malaysia. BMJ Open. 2019;9:e025322.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Masahiro Suzuki.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Suzuki, M., Saito, Y., Kitahara, H. et al. Impact of in-hospital blood pressure variability on clinical outcomes in patients with symptomatic peripheral arterial disease. Hypertens Res (2021).

Download citation


  • Blood pressure variability
  • Endovascular therapy
  • Peripheral artery disease


Quick links